{
    "organizations": [],
    "uuid": "6fd4625286e3895df08333944ba60c56e4668c17",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncology-venture-and-medical-progn/brief-oncology-venture-and-medical-prognosis-institute-agree-on-joint-merger-plan-idUSFWN1QR066",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncology Venture And Medical Prognosis Institute Agree On Joint Merger Plan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 9 (Reuters) - ONCOLOGY VENTURE SWEDEN AB:\n* PROPOSED MERGER BETWEEN ONCOLOGY VENTURE AND MEDICAL PROGNOSIS INSTITUTE\n* MERGER WILL BE IMPLEMENTED WITH MPI AS CONTINUING LEGAL ENTITY AND OV AS DISCONTINUING ENTITY​\n* ‍FOLLOWING COMPLETION OF MERGER COMBINED COMPANY WILL BE REFERRED TO AS ‘ONCOLOGY VENTURE’​\n* ‍EXPECTED OPERATIONAL SYNERGIES AMOUNT TO MORE THAN SEK 2 MILLION PER YEAR.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-09T15:09:00.000+02:00",
    "crawled": "2018-03-10T20:01:44.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "oncology",
        "venture",
        "sweden",
        "ab",
        "proposed",
        "merger",
        "oncology",
        "venture",
        "medical",
        "prognosis",
        "institute",
        "merger",
        "implemented",
        "mpi",
        "continuing",
        "legal",
        "entity",
        "ov",
        "discontinuing",
        "completion",
        "merger",
        "combined",
        "company",
        "referred",
        "oncology",
        "venture",
        "operational",
        "synergy",
        "amount",
        "sek",
        "million",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}